BOEUF
+0.0 · +0.00%
USD · PINK

Bonesupport Holding AB (publ)(BOEUF) Stock Analysis | Healthcare

USD --+0.00%
Reward75High
Risk23Low
75%Data
Strong 15% profit margin · Revenue growing 14% YoY
Quality Compounder
Market Cap:1.57Bn
ⓘ
Reward Rating
75
High
Reward Assessment
75% data coverage
Top 10% of stocksView factors
ⓘ
Risk Rating
23
Low
Risk Assessment
1 metric flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on BOEUF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for BOEUF, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Bonesupport Holding AB (publ)?

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

BOEUF · Verdict

Strong reward · low risk

BOEUF scores well on profitability and cash flow with no major weaknesses flagged in the model.

Based on 88% data coverage

BOEUF · Verdict

What’s working & what to watch

Strengths 5

  • Profitability95/100

    12% net margin · 22% ROE

  • Cash flow91/100

    19% free-cash-flow margin

  • Growth90/100

    Revenue +52.7% CAGR

  • Volatility80/100

    Top decile vs peers

  • Balance sheet76/100

    Current ratio 4.85

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Bonesupport Holding AB (publ)?

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.57B, and a P/E ratio of 79.3x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: High (75)

The scoring profile indicates a strong reward potential, driven primarily by profitability and growth. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Medical Instruments & Supplies names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorHealthcare
IndustryMedical Instruments & Supplies
Market Cap1.57B
P/E Ratio79.3333
Dividend YieldN/A
Beta0.453
Insider Activity
12M windowNo data
No insider activity data available for this ticker.